These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18411020)

  • 1. Re: subcutaneous methadone-an issue revisited.
    Vielvoye-Kerkmeer AP; van Mansom I
    J Pain Symptom Manage; 2008 Jun; 35(6):572. PubMed ID: 18411020
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C; Vara F
    J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching from methadone to tapentadol for cancer pain.
    Mercadante S; Ferrera P; Adile C
    J Pain Symptom Manage; 2012 Sep; 44(3):e3-5. PubMed ID: 22819437
    [No Abstract]   [Full Text] [Related]  

  • 4. Subcutaneous methadone--an issue revisited.
    Hum A; Fainsinger RL; Bielech M
    J Pain Symptom Manage; 2007 Dec; 34(6):573-5. PubMed ID: 17959347
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on Ripamonti et al., Pain, 70 (1997) 109-115.
    Morley JS; Makin MK
    Pain; 1997 Oct; 73(1):114-5. PubMed ID: 9414068
    [No Abstract]   [Full Text] [Related]  

  • 6. Parenteral methadone: an essential medication for the treatment of pain.
    Manfredi PL; Foley KM; Payne R; Houde R; Inturrisi CE
    J Pain Symptom Manage; 2003 Aug; 26(2):687-8. PubMed ID: 12906950
    [No Abstract]   [Full Text] [Related]  

  • 7. Methadone as an analgesic: a review of the risks and benefits.
    Terpening CM; Johnson WM
    W V Med J; 2007; 103(1):14-8. PubMed ID: 17432310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased assessment and monitoring needed for patients receiving methadone.
    Merlo LJ; Gold MS
    Am J Med; 2008 May; 121(5):e23; author repply e25. PubMed ID: 18456018
    [No Abstract]   [Full Text] [Related]  

  • 9. Methadone:effective analgesia, confusion, and risk.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2005; 19(2):3-5. PubMed ID: 16061455
    [No Abstract]   [Full Text] [Related]  

  • 10. Methadone for pain: limited evidence, tenuous guidelines.
    Newman RG
    J Pain; 2009 Jul; 10(7):774-5; author reply 776. PubMed ID: 19559393
    [No Abstract]   [Full Text] [Related]  

  • 11. Methadone analgesia for persistent pain: safety and toxicity considerations.
    Burgess FW; Pawasauskas J
    Med Health R I; 2008 Sep; 91(9):273-5. PubMed ID: 18834044
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methadone in the treatment of chronic non-malignant pain].
    Bendiksen A; McGehee E; Handberg G
    Ugeskr Laeger; 2007 Apr; 169(17):1568-72. PubMed ID: 17484827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing methadone, a unique analgesic.
    Manfredi PL; Houde RW
    J Support Oncol; 2003; 1(3):216-20. PubMed ID: 15334878
    [No Abstract]   [Full Text] [Related]  

  • 14. Very-high-dose methadone with minimal toxicity and inadequate pain control in a hospice patient with cancer.
    Latuga NM; Wahler RG
    J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):143-9. PubMed ID: 23646910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone: applied pharmacology and use as adjunctive treatment in chronic pain.
    Brown R; Kraus C; Fleming M; Reddy S
    Postgrad Med J; 2004 Nov; 80(949):654-9. PubMed ID: 15537850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting comfortable with methadone.
    J Support Oncol; 2003; 1(1):52. PubMed ID: 15352643
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating opioid dependency and coexistent chronic nonmalignant pain.
    Blondell RD; Ashrafioun L
    Am Fam Physician; 2008 Nov; 78(10):1132-3. PubMed ID: 19035061
    [No Abstract]   [Full Text] [Related]  

  • 18. Methadone in end-of-life pain management.
    Chau DL; Mason MN
    J Opioid Manag; 2005; 1(5):244-8. PubMed ID: 17319557
    [No Abstract]   [Full Text] [Related]  

  • 19. Transitioning a cancer patient from high-dose intravenous hydromorphone therapy to intravenous methadone.
    LeBaron V; Brody J; Lee EM; Hardin C; Snyder L
    J Pain Palliat Care Pharmacother; 2011; 25(4):356-61. PubMed ID: 22126165
    [No Abstract]   [Full Text] [Related]  

  • 20. Methadone: friend or foe?
    Jackson WC
    Tenn Med; 2011 Apr; 104(4):39-41. PubMed ID: 21560909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.